TSXV:BTI.H - Post by User
Comment by
prophetoffactzon Jan 16, 2023 2:21pm
118 Views
Post# 35226173
RE:RE:RE:Forcing Bioasis to Answer
RE:RE:RE:Forcing Bioasis to Answer "Cresence was Plan B?!!!???
The Cresence people got 6 million shares or so. Those shares are now worth about $250,000. They aren't Plan B and they never were Plan B. In my opinion, they were likely part of a storyboard developed to promote this sellout."
I said Cresence appears to have been 'Plan A' with the J&J and Neuramedy deals. Marketing BTI as a Phase II clinical stage company they appeared to hope to catalyze new interest in BTI with the Phase II Cresence assets with the J&J and Neuramedy deals on xB3 also. They had hoped for a NASDAQ listing. The called the Cresence deal transformational. That BTI only paid 6 million shares for the Cresence assets can speak to the potential value of xB3 relative to the Cresence assets and could further serve as validation for the xB3 assets. 'Plan A' didn't get the market excited, BTI couldn't launch to NASDAQ, and then BTI missed its debt payments. 'Plan B' appears to be Midatech.